Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy-Reference-Cited by-同舟云学术

Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy

Published:2003-09 Issue:13 Volume:17 Page:1907-1915
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Hunt Peter W,Deeks Steven G,Rodriguez Benigno,Valdez Hernan,Shade Starley B,Abrams Donald I,Kitahata Mari M,Krone Melissa,Neilands Torsten B,Brand Richard J,Lederman Michael M,Martin Jeffrey N

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference33 articles.

1. Immune Reconstitution after 2 Years of Successful Potent Antiretroviral Therapy in Previously Untreated Human Immunodeficiency Virus Type 1–Infected Adults

2. 3-Year Suppression of HIV Viremia with Indinavir, Zidovudine, and Lamivudine

3. Increase and Plateau of CD4 T-Cell Counts in the 3½ Years After Initiation of Potent Antiretroviral Therapy

4. Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy

5. Full suppression of viral load is needed to achieve an optimal CD4 cell count response among patients on triple drug antiretroviral therapy

Cited by 242 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trajectories of CD4 T‐cell count, CD8 T‐cell count, and CD4/CD8 ratio in patients with HIV and long‐term virological suppression based on Yunnan HIV cohort;HIV Medicine;2024-09-02

2. Temporal changes in plasma metabolic signatures to predict immune response of antiretroviral therapy among people living with HIV;Journal of Medical Virology;2024-07-26

3. COVID-19 Outcomes among People Living with HIV in Colorado;AIDS and Behavior;2024-06-25

4. Factors associated with immunological non-response after ART initiation: a retrospective observational cohort study;BMC Infectious Diseases;2024-01-29

5. Dominant CD4+ T cell receptors remain stable throughout antiretroviral therapy-mediated immune restoration in people with HIV;Cell Reports Medicine;2023-11